|
SEC22A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.746300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.267000E-01 |
| Normal-vs-Stage2 |
2.053400E-01 |
| Normal-vs-Stage3 |
7.286000E-01 |
| Normal-vs-Stage4 |
7.851600E-01 |
| Stage1-vs-Stage2 |
2.677400E-01 |
| Stage1-vs-Stage3 |
9.627800E-01 |
| Stage1-vs-Stage4 |
9.075800E-01 |
| Stage2-vs-Stage3 |
3.995600E-01 |
| Stage2-vs-Stage4 |
7.128000E-01 |
| Stage3-vs-Stage4 |
8.993600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.211900E-02 |
| Normal-vs-AfricanAmerican |
3.570800E-01 |
| Normal-vs-Asian |
1.783190E-01 |
| Caucasian-vs-AfricanAmerican |
4.342200E-01 |
| Caucasian-vs-Asian |
8.003800E-01 |
| AfricanAmerican-vs-Asian |
5.749200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.687230E-01 |
| Normal-vs-Female |
7.724800E-03 |
| Male-vs-Female |
3.931900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.318400E-01 |
| Normal-vs-Extreme_Weight |
5.732400E-01 |
| Normal-vs-Obese |
1.952020E-01 |
| Normal-vs-Extreme_Obese |
7.998400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.126200E-01 |
| Normal_Weight-vs-Obese |
6.561000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.580000E-01 |
| Extreme_Weight-vs-Obese |
3.901200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.419800E-01 |
| Obese-vs-Extreme_Obese |
7.443400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.772330E-02 |
| Normal-vs-Age(41-60Yrs) |
2.438100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.221800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.128200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.450600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.319200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.281800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.255600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.053000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.564400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.085940E-02 |
| Normal-VS-Type2 PRCC |
6.587200E-01 |
| Normal-VS-KIRP CIMP |
1.358430E-01 |
| Normal-VS-Unclassified PRCC |
1.777420E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.419900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.557600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.976800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.104010E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.091770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.316600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.088400E-01 |
| Normal-vs-N1 |
1.809980E-01 |
| Normal-vs-N2 |
6.680200E-01 |
| N0-vs-N1 |
1.007390E-01 |
| N0-vs-N2 |
6.468600E-01 |
| N1-vs-N2 |
8.623600E-01 |
|
|
